The spindle assembly checkpoint is a therapeutic vulnerability of CDK4/6 inhibitor-resistant ER+ breast cancer with

Isabel Soria-Bretones1,2,3, Kelsie L Thu1,4,5, Jennifer Silvester1

  • 1Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.

Science Advances
|September 7, 2022
PubMed

Insights

A subset of estrogen receptor-positive (ER+) metastatic breast cancer resistant to CDK4/6 inhibitors develops defects in cell division. These defects make the cancer vulnerable to TTK inhibitors like CFI-402257.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Therapeutics

Background:

  • Cyclin-dependent kinases 4 and 6 inhibitors (CDK4/6i) are a standard treatment for ER+ metastatic breast cancer.
  • Acquired resistance to CDK4/6i is a significant clinical challenge, necessitating the characterization of resistance mechanisms and vulnerabilities.

Purpose of the Study:

  • To investigate the molecular phenotypes and exploitable vulnerabilities in CDK4/6i-resistant breast cancer.
  • To identify potential therapeutic strategies for patients with acquired resistance to CDK4/6i.

Main Methods:

  • Development of CDK4/6i-resistant breast cancer cell lines and patient-derived organoids.
  • Analysis of mitotic fidelity and chromosomal segregation in resistant models.
  • Evaluation of sensitivity to inhibitors of mitotic checkpoint regulators, specifically TTK and Aurora kinase A/B.
  • Assessment of the efficacy of the TTK inhibitor CFI-402257 in resistant models.

Main Results:

  • A subset of CDK4/6i-resistant models exhibited mitotic segregation errors and micronuclei formation.
  • Loss of RB1, a known resistance mechanism, was associated with these mitotic defects.
  • These defects conferred enhanced sensitivity to TTK inhibition.
  • Treatment with CFI-402257 induced premature chromosome segregation, DNA damage, and cell death in sensitive models.

Conclusions:

  • Mitotic defects and sensitivity to TTK inhibition represent a vulnerability in a subset of CDK4/6i-resistant ER+ breast cancers.
  • The TTK inhibitor CFI-402257 shows therapeutic potential for this specific patient population.
  • Targeting mitotic checkpoint regulators offers a promising strategy to overcome CDK4/6i resistance in breast cancer.

Related Concept Videos

The Spindle Assembly Checkpoint02:19

The Spindle Assembly Checkpoint

The spindle assembly checkpoint is a molecular surveillance mechanism ensuring the fidelity of chromosome segregation during anaphase. The checkpoint monitors the completion of all the prerequisite steps before chromosome segregation to determine whether the segregation process should proceed or be delayed.
Many proteins function together to control the spindle assembly checkpoint. Mutations affecting these proteins may allow cells to proceed into anaphase prematurely, resulting in the...
3.2K
Separation of Sister Chromatids02:17

Separation of Sister Chromatids

At the transition from prophase to metaphase, there is a reduction in cohesion along the chromosomal arms, resulting in the resolution of sister chromatids. However, residual cohesin connections remain to hold the sister chromatids together until the transition from metaphase to anaphase. The residual connection prevents any premature separation of sister chromatids, blocking the risks of aneuploidy within the daughter cells.
At the onset of anaphase, separase, a proteolytic enzyme, is...
3.8K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.9K
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
5.7K
DNA Damage can Stall the Cell Cycle02:37

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.3K
The Mitotic Spindle02:27

The Mitotic Spindle

The mitotic spindle—or spindle apparatus—is a eukaryotic, cytoskeletal structure made up of long protein fibers called microtubules. Formed during cell division, the spindle separates sister chromatids and moves them to opposite ends of a parental cell, where the now individual chromosomes are distributed to two daughter cell nuclei.
The bipolar configuration of the mitotic spindle facilitates chromosomal segregation, preparing the cell for division. One mechanism that ensures...
6.7K